SCHEDULE 13G

Statement of Beneficial Ownership

ARS Pharmaceuticals, Inc. Filed 2026-02-13 Acc 0001104659-26-015245

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-03-24 SCHEDULE 13G Statement of Beneficial Ownership
2026-02-13 SCHEDULE 13G Statement of Beneficial Ownership
2026-01-21 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

External

SEC EDGAR (opens in new tab)